Application 761411

Type
BLA
Sponsor
INCYTE CORP

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761411Niktimvoaxatilimab-csfr351(a)Disc2026-09-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NIKTIMVOaxatilimab-csfrINJECTABLE;INTRAVENOUS50 MG/MLNoNo

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
79627ORIG 2024-09-16
79412ORIG 2024-08-16
79398ORIG 2024-08-14